University of Oklahoma-College of Medicine: Stephenson Cancer Center Part of Trial Resulting in New Treatment for Metastatic Prostate Cancer
June 27, 2020
June 27, 2020
OKLAHOMA CITY, Oklahoma, June 27 -- The University of Oklahoma's College of Medicine issued the following news:
Stephenson Cancer Center at OU Medicine took part in an international clinical trial that proved the effectiveness of an oral medication for metastatic prostate cancer, the first treatment advance for that disease in many years.
Results of the trial, which studied the drug relugolix, were published in the prestigious New England Journal of Medicine. One o . . .
Stephenson Cancer Center at OU Medicine took part in an international clinical trial that proved the effectiveness of an oral medication for metastatic prostate cancer, the first treatment advance for that disease in many years.
Results of the trial, which studied the drug relugolix, were published in the prestigious New England Journal of Medicine. One o . . .